Search results for "Positron-emission tomography"

showing 10 items of 228 documents

Differentiation of benign and malignant lymph nodes in pediatric patients on ferumoxytol-enhanced PET/MRI.

2019

The composition of lymph nodes in pediatric patients is different from that in adults. Most notably, normal lymph nodes in children contain less macrophages. Therefore, previously described biodistributions of iron oxide nanoparticles in benign and malignant lymph nodes of adult patients may not apply to children. The purpose of our study was to evaluate if the iron supplement ferumoxytol improves the differentiation of benign and malignant lymph nodes in pediatric cancer patients on 18F-FDG PET/MRI. Methods: We conducted a prospective clinical trial from May 2015 to December 2018 to investigate the value of ferumoxytol nanoparticles for staging of children with cancer with 18F-FDG PET/MRI.…

Malemedicine.medical_specialtyAdolescentAnemiaMRI contrast agentMedicine (miscellaneous)030218 nuclear medicine & medical imagingLesioncancer imaging03 medical and health sciences0302 clinical medicineFluorodeoxyglucose F18lymph nodesNeoplasmsferumoxytolmedicineHumansProspective StudiesChildPharmacology Toxicology and Pharmaceutics (miscellaneous)Lymph nodeReceiver operating characteristicbusiness.industryCell Differentiationmedicine.diseasePediatric cancerMagnetic Resonance ImagingFerrosoferric Oxide3. Good healthFerumoxytolmedicine.anatomical_structurePET/MRI030220 oncology & carcinogenesisPositron-Emission TomographyNanoparticlesFemaleRadiologyLymphmedicine.symptomRadiopharmaceuticalsbusinessResearch PaperTheranostics
researchProduct

Association between Cognitive Performance and Cortical Glucose Metabolism in Patients with Mild Alzheimer’s Disease

2004

<i>Background:</i> Neuronal and synaptic function in Alzheimer’s disease (AD) is measured in vivo by glucose metabolism using positron emission tomography (PET). <i>Objective:</i> We hypothesized that neuronal activation as measured by PET is a more sensitive index of neuronal dysfunction than activity during rest. We investigated if the correlations between dementia severity as measured with the Mini Mental State Examination (MMSE) and glucose metabolism are an artifact of brain atrophy. <i>Method:</i> Glucose metabolism was measured using [<sup>18</sup>F]fluorodeoxyglucose PET during rest and activation due to audiovisual stimulation in 13 m…

Malemedicine.medical_specialtyCognitive NeuroscienceCentral nervous system diseaseCognitionDegenerative diseaseAtrophyAlzheimer DiseaseFluorodeoxyglucose F18Internal medicinemedicineHumansDementiaBrain atrophy;Partial volume effects;Alzheimer’s disease;Metabolism;Brain imaging techniquesAgedCerebral CortexMini–Mental State Examinationmedicine.diagnostic_testBrainMiddle Agedmedicine.diseaseddc:Psychiatry and Mental healthGlucoseEndocrinologyPositron emission tomographyPositron-Emission TomographyPosterior cingulateFemaleAtrophyGeriatrics and GerontologyAlzheimer's diseaseMental Status SchedulePsychologyDementia and Geriatric Cognitive Disorders
researchProduct

Transmurality of scar influences the effect of a hybrid-intervention with autologous bone marrow cell injection and aortocoronary bypass surgery (MNC…

2010

Abstract Background Cell therapy (CTx) is a strategy to support cardiac regeneration after myocardial infarction (MI). Thus far, clinical studies provided mixed results. Here, we investigated whether transmurality of the infarct may play a relevant role. Methods 18 patients (63±3years, 15 male) undergoing elective coronary artery bypass graft (CABG) surgery 2.2±0.7months post MI participated. 10 had transmural and 8 non-transmural infarct scars assessed by Tc-99m-MIBI Single-Photon Emission Computed Tomography (SPECT) and F18-FDG-Positron-Emission-Tomography (PET). During surgery, 10ml of sternal bone marrow were obtained, mononuclear cells (MNC) were isolated. At the end of surgery MNC wer…

Malemedicine.medical_specialtyMyocardial InfarctionMedizinScarsTransplantation AutologousPeripheral blood mononuclear cellInjectionsCell therapyCicatrixInternal medicinemedicineHumansMyocardial infarctionCoronary Artery BypassAgedBone Marrow TransplantationTomography Emission-Computed Single-PhotonEjection fractionmedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseSurgeryTreatment Outcomemedicine.anatomical_structurePositron-Emission TomographyCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessPerfusionEmission computed tomographyArteryInternational Journal of Cardiology
researchProduct

Stage-dependent agreement between cerebrospinal fluid proteins and FDG-PET findings in Alzheimer's disease.

2011

Cerebral hypometabolism and abnormal levels of amyloid beta (Aβ), total (t-tau) and phosphorylated tau (ptau) proteins in cerebrospinal fluid (CSF) are established biomarkers of Alzheimer's disease (AD). We examined the agreement between these biomarkers in a single center study of patients with AD of severity extending over a wide range. Forty seven patients (MMSE 21.4 ± 3.6, range 13-28 points) with incipient and probable AD underwent positron emission tomography with [18F]-fluorodeoxyglucose (FDG-PET) and lumbar puncture for CSF assays of Aβ1-42, p-tau181, and t-tau. All findings were classified as either positive or negative for AD. Statistical analyses were performed for the whole samp…

Malemedicine.medical_specialtyPathologyAmyloid betaApolipoprotein E4tau ProteinsNeuropsychological TestsGastroenterologySensitivity and SpecificityCerebrospinal fluidAlzheimer DiseaseFluorodeoxyglucose F18Internal medicinemental disordersmedicineDementiaHumansAgedRetrospective StudiesPsychiatric Status Rating ScalesAmyloid beta-Peptidesmedicine.diagnostic_testbiologyLumbar punctureNeurodegenerationCerebrospinal Fluid ProteinsMiddle Agedmedicine.diseasePeptide FragmentsNeurologyPositron emission tomographyArea Under CurvePositron-Emission Tomographybiology.proteinFemaleNeurology (clinical)Alzheimer's diseasePsychologyCognition DisordersKappaBiomarkersFollow-Up StudiesCurrent Alzheimer research
researchProduct

Impact of 18F-Choline PET/CT in the Decision-Making Strategy of Treatment Volumes in Definitive Prostate Cancer Volumetric Modulated Radiation Therapy

2015

INTRODUCTION Aim of the study is to evaluate the impact of Cho-PET/CT in decision-making strategy of patients with localized prostate cancer (PC) eligible to definitive radiotherapy (RT). MATERIALS AND METHODS Sixty patients Cho-PET/CT before RT were prospectively enrolled. All patients were treated with volumetric modulated arc therapy with simultaneous integrated boost in 28 fractions. Androgen deprivation therapy was prescribed according to National Comprehensive Cancer Network (NCCN) risk classification. Therapeutic strategy based on the Cho-PET/CT evaluation was compared with the strategy that would have been proposed in case of PET not available and/or not strictly indicated, accordin…

Malemedicine.medical_specialtyRadical treatmentmedicine.medical_treatmentClinical Decision-Making18F-cholineMultimodal ImagingCholineAndrogen deprivation therapyProstate cancerProstateNuclear Medicine and ImagingIntensity-ModulatedMedicineHumansRadiology Nuclear Medicine and imagingRadiation treatment planningTomographyAgedPET-CTProstate cancerRadiotherapybusiness.industryCancerProstatic NeoplasmsGeneral MedicineMiddle Agedmedicine.diseaseX-Ray ComputedRadiation therapymedicine.anatomical_structurePositron-Emission TomographyRadiologyCho-PET/CT; Prostate cancer; Radical treatment; Radiotherapy; Aged; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Prostatic Neoplasms; Radiopharmaceuticals; Clinical Decision-Making; Positron-Emission Tomography; Radiotherapy Intensity-Modulated; Tomography X-Ray Computed; Radiology Nuclear Medicine and ImagingRadiotherapy Intensity-ModulatedRadiopharmaceuticalsbusinessNuclear medicineRadiologyTomography X-Ray ComputedCho-PET/CT
researchProduct

FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment

2006

Specific patterns of cortical glucose metabolism disturbances and increased CSF phospho-tau (p-tau(181)) concentrations could be demonstrated to predict cognitive decline and shift to dementia in amnestic mild cognitive impairment (MCI). But comparisons of both diagnostic tools have not been undertaken so far. The aim of the study was to compare (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) findings and CSF phospho-tau (p-tau(181)) measurements in the prediction of cognitive deterioration and conversion to dementia in MCI. During follow-up (mean 19 months) eight of 16 patients (50%) showed progressive cognitive decline, and four patients shifted to dementia. Patholog…

Malemedicine.medical_specialtyTau proteinNeuroscience (miscellaneous)tau ProteinsKaplan-Meier EstimateSeverity of Illness IndexStereotaxic TechniquesCentral nervous system diseaseImaging Three-DimensionalDegenerative diseaseFluorodeoxyglucose F18Internal medicinemental disordersSeverity of illnessImage Processing Computer-AssistedmedicineHumansDementiaRadiology Nuclear Medicine and imagingLongitudinal StudiesCognitive declineAgedPsychiatric Status Rating ScalesbiologyCognitive disorderPrognosismedicine.diseasePsychiatry and Mental healthPositron-Emission TomographyStereotaxic techniquebiology.proteinCardiologyDementiaFemaleCognition DisordersMental Status SchedulePsychologyNeuroscienceBiomarkersFollow-Up StudiesPsychiatry Research: Neuroimaging
researchProduct

Blood-brain barrier disruption by low-frequency ultrasound.

2006

Background and Purpose— A recent study showed a dramatic increase in cerebral hemorrhage comprising atypical locations with low-frequency ultrasound–mediated recombinant tissue plasminogen activator–thrombolysis in humans. Here, we provide a possible explanation for this phenomenon by a side effect observed in a study using the similar ultrasound device. Methods— The study was originally undertaken to investigate by transcranial Doppler sonography, positron emission tomography and perfusion MRI whether transcranial application of wide-field low-frequency ultrasound (300 kHz) improves cerebral hemodynamics in patients with cerebral small vessel disease. Results— Showing no clear positive ef…

Malemedicine.medical_specialtyUltrasonography Doppler TranscranialUltrasonic TherapyPerfusion scanningBrain IschemiaBrain ischemiaParietal LobemedicineHumansCerebral perfusion pressureStrokeAgedAdvanced and Specialized Nursingmedicine.diagnostic_testbusiness.industryUltrasoundHemodynamicsMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingFrontal LobePositron emission tomographyBlood-Brain BarrierCerebrovascular CirculationPositron-Emission TomographyNeurology (clinical)RadiologyCardiology and Cardiovascular MedicinebusinessPerfusionExtravasation of Diagnostic and Therapeutic MaterialsStroke
researchProduct

Neuronal Correlates of Clinical Asymmetry in Progressive Supranuclear Palsy

2014

Progressive supranuclear palsy (PSP) is characterized by a symmetric hypokinetic syndrome with early falls and vertical supranuclear gaze palsy. However, clinically asymmetric manifestations occur, resembling idiopathic Parkinson disease or corticobasal degeneration. The aim of this study was to determine the neuronal correlates of patients suffering from PSP with a lateralized disease manifestation (hemi-PSP) in comparison to patients with symmetric clinical presentation (symPSP) and corticobasal degeneration.Twenty-three patients with PSP and 8 patients with corticobasal degeneration according to standard diagnostic criteria underwent F-fluorodeoxyglucose (FDG) PET scans to assess disease…

Malemedicine.medical_specialtybehavioral disciplines and activitiesBrain mappingProgressive supranuclear palsyPhysical medicine and rehabilitationFluorodeoxyglucose F18mental disordersHumansMedicineCorticobasal degenerationRadiology Nuclear Medicine and imagingAgedAged 80 and overNeuronsBrain MappingVertical supranuclear gaze palsybusiness.industryGeneral MedicinePrognosismedicine.diseaseeye diseasesnervous system diseasesSupranuclear palsyPositron-Emission TomographyFemaleSupranuclear Palsy ProgressivebusinessClinical Nuclear Medicine
researchProduct

A case of post-traumatic complex auditory hallucinosis treated with rTMS.

2010

Previous studies of auditory hallucinations in schizophrenia found that the hallucinations were reduced by the application of transcranial magnetic stimulation (rTMS). Here we describe a case of traumatic brain injury associated with continuous music hallucinations. An MRI scan showed a structural lesion of the right temporal pole and a PET scan indicated a hyperactive area of the posterior right temporal lobe. We hypothesized that rTMS applied to the right temporal area would reduce this activity and the corresponding hallucinations. The patient's music hallucinations were significantly reduced by rTMS treatment. A PET scan following treatment also indicated that rTMS treatment reduced bra…

Malemedicine.medical_specialtypost-traumatic complex auditory hallucinosis rTMS.HallucinationsTraumatic brain injuryBrain activity and meditationmedicine.medical_treatmentAudiologybehavioral disciplines and activitiesHallucinosisSettore BIO/09 - FisiologiaTemporal lobeLesionArts and Humanities (miscellaneous)mental disordersmedicineHumansmedicine.diagnostic_testSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingTranscranial Magnetic StimulationTemporal LobeTranscranial magnetic stimulationSchizophreniaBrain InjuriesPositron-Emission TomographySettore MED/26 - NeurologiaNeurology (clinical)medicine.symptomPsychologyNeuroscienceMusic
researchProduct

Scandium-44: Benefits of a Long-Lived PET Radionuclide Available from the 44Ti/44Sc Generator System

2011

(44)Ti/(44)Sc radionuclide generators are of interest for molecular imaging. The 3.97 hours half-life of (44)Sc and its high positron branching of 94.27% may stimulate the application of (44)Sc-labeled PET radiopharmaceuticals. This review describes the current status of (44)Ti production, (44)Ti/(44)Sc radionuclide generator development, post-processing of generator eluates towards medical application, identification of ligands adequate to Sc(III) co-ordination chemistry, proof-of-principle labeling of (44)Sc-DOTA-octreotides, investigation of in vitro and in vivo parameters, and initial applications for molecular imaging - both in small animals and humans.

Materials scienceTransplantation HeterologousMice Nudechemistry.chemical_elementHeterocyclic Compounds 1-RingMicePositronDrug StabilityNickelNuclear ReactorsmedicineAnimalsHumansRadiology Nuclear Medicine and imagingCation Exchange ResinsScandiumChelating AgentsMice nudeRadioisotopesTitaniumPharmacologyRadionuclidemedicine.diagnostic_testRadionuclide GeneratorsLiver NeoplasmsNeoplasms ExperimentalTransplantationchemistryPositron emission tomographyPositron-Emission TomographyPuromycinAdsorptionRadiopharmaceuticalsRadionuclide GeneratorMolecular imagingScandiumHalf-LifeNuclear chemistryCurrent Radiopharmaceuticals
researchProduct